Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-05-28

AUTHORS

Valtteri Kaasinen, Maija Kinos, Juho Joutsa, Marko Seppänen, Tommi Noponen

ABSTRACT

PurposeParkinson’s disease (PD) can manifest with a tremor-dominant or a non-tremor (akinetic-rigid) phenotype. Although the tremor-dominant subtype may show a better prognosis, there is limited information on the phenotypic differences regarding the level of striatal dopamine transmission. The present study investigated striatal dopamine transporter (DAT) binding characteristics in a large sample of patients with and without tremor.Methods[123I]FP-CIT SPECT scans of 231 patients with a clinical diagnosis of PD and abnormal FP-CIT binding (157 with tremor, 74 without tremor) and 230 control patients with normal FP-CIT binding (148 with tremor, 82 without tremor) were analysed using an automated region-of-interest analysis of the scans (BRASS). Specific striatal binding ratios were compared between phenotypes and groups using age, sex, and symptom duration, predominant side of symptoms, dopaminergic medications and scanner as covariates.ResultsPatients with PD had 28.1 – 65.0 % lower binding in all striatal regions compared to controls (p < 0.001). The mean FP-CIT caudate nucleus uptake and the left caudate nucleus uptake were higher in PD patients with tremor than in PD patients without tremor (mean 9.0 % higher, left 10.5 % higher; p < 0.05), whereas there were no differences between tremor and non-tremor control patients. No significant effects of tremor on DAT binding were observed in the anterior or posterior putamen.ConclusionThe motor phenotype is associated with the extent of caudate dopamine terminal loss in PD, as dopamine function is relatively more preserved in tremor patients. Symptom type is related to caudate dopamine function only in association with Parkinsonian dopaminergic degeneration, not in intact dopamine systems in patients with non-PD tremor. More... »

PAGES

1931-1937

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-014-2796-5

DOI

http://dx.doi.org/10.1007/s00259-014-2796-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036293310

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24867256


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dopamine Plasma Membrane Transport Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neostriatum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parkinson Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Binding", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tomography, Emission-Computed, Single-Photon", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tremor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tropanes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Division of Clinical Neurosciences, University of Turku and Turku University Hospital, POB 52, 20521, Turku, Finland", 
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaasinen", 
        "givenName": "Valtteri", 
        "id": "sg:person.0661656645.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661656645.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Division of Clinical Neurosciences, University of Turku and Turku University Hospital, POB 52, 20521, Turku, Finland", 
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kinos", 
        "givenName": "Maija", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Division of Clinical Neurosciences, University of Turku and Turku University Hospital, POB 52, 20521, Turku, Finland", 
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joutsa", 
        "givenName": "Juho", 
        "id": "sg:person.0631212202.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631212202.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
            "Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sepp\u00e4nen", 
        "givenName": "Marko", 
        "id": "sg:person.01231750412.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231750412.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noponen", 
        "givenName": "Tommi", 
        "id": "sg:person.015673636475.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015673636475.93"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00259-012-2232-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004544665", 
          "https://doi.org/10.1007/s00259-012-2232-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-012-2276-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008102551", 
          "https://doi.org/10.1007/s00259-012-2276-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrneurol.2009.196", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037082578", 
          "https://doi.org/10.1038/nrneurol.2009.196"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00702-006-0518-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051880746", 
          "https://doi.org/10.1007/s00702-006-0518-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-05-28", 
    "datePublishedReg": "2014-05-28", 
    "description": "PurposeParkinson\u2019s disease (PD) can manifest with a tremor-dominant or a non-tremor (akinetic-rigid) phenotype. Although the tremor-dominant subtype may show a better prognosis, there is limited information on the phenotypic differences regarding the level of striatal dopamine transmission. The present study investigated striatal dopamine transporter (DAT) binding characteristics in a large sample of patients with and without tremor.Methods[123I]FP-CIT SPECT scans of 231 patients with a clinical diagnosis of PD and abnormal FP-CIT binding (157 with tremor, 74 without tremor) and 230 control patients with normal FP-CIT binding (148 with tremor, 82 without tremor) were analysed using an automated region-of-interest analysis of the scans (BRASS). Specific striatal binding ratios were compared between phenotypes and groups using age, sex, and symptom duration, predominant side of symptoms, dopaminergic medications and scanner as covariates.ResultsPatients with PD had 28.1\u00a0\u2013\u00a065.0\u00a0% lower binding in all striatal regions compared to controls (p\u2009<\u20090.001). The mean FP-CIT caudate nucleus uptake and the left caudate nucleus uptake were higher in PD patients with tremor than in PD patients without tremor (mean 9.0\u00a0% higher, left 10.5\u00a0% higher; p\u2009<\u20090.05), whereas there were no differences between tremor and non-tremor control patients. No significant effects of tremor on DAT binding were observed in the anterior or posterior putamen.ConclusionThe motor phenotype is associated with the extent of caudate dopamine terminal loss in PD, as dopamine function is relatively more preserved in tremor patients. Symptom type is related to caudate dopamine function only in association with Parkinsonian dopaminergic degeneration, not in intact dopamine systems in patients with non-PD tremor.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-014-2796-5", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "41"
      }
    ], 
    "keywords": [
      "FP-CIT binding", 
      "PurposeParkinson\u2019s disease", 
      "control patients", 
      "PD patients", 
      "dopamine function", 
      "dopamine transporter", 
      "striatal dopamine transporter density", 
      "tremor-dominant subtype", 
      "dopamine terminal loss", 
      "intact dopamine system", 
      "striatal dopamine transmission", 
      "striatal dopamine transporter", 
      "striatal binding ratios", 
      "CIT SPECT scans", 
      "dopamine transporter density", 
      "nucleus uptake", 
      "symptom duration", 
      "dopaminergic medication", 
      "better prognosis", 
      "dopaminergic degeneration", 
      "DAT binding", 
      "posterior putamen", 
      "motor phenotype", 
      "dopamine transmission", 
      "striatal regions", 
      "Parkinson's disease", 
      "SPECT scans", 
      "predominant side", 
      "patients", 
      "dopamine system", 
      "transporter density", 
      "clinical diagnosis", 
      "tremor patients", 
      "disease", 
      "interest analysis", 
      "tremor", 
      "terminal loss", 
      "symptom type", 
      "low binding", 
      "present study", 
      "binding ratios", 
      "scans", 
      "phenotype", 
      "limited information", 
      "ResultsPatients", 
      "medications", 
      "prognosis", 
      "putamen", 
      "symptoms", 
      "subtypes", 
      "anterior", 
      "differences", 
      "large sample", 
      "degeneration", 
      "diagnosis", 
      "uptake", 
      "significant effect", 
      "phenotypic differences", 
      "binding", 
      "age", 
      "sex", 
      "association", 
      "duration", 
      "covariates", 
      "group", 
      "transporters", 
      "function", 
      "levels", 
      "control", 
      "study", 
      "loss", 
      "effect", 
      "transmission", 
      "scanner", 
      "extent", 
      "samples", 
      "region", 
      "ratio", 
      "types", 
      "side", 
      "analysis", 
      "characteristics", 
      "information", 
      "system", 
      "density", 
      "non-tremor (akinetic-rigid) phenotype", 
      "abnormal FP-CIT binding", 
      "normal FP-CIT binding", 
      "Specific striatal binding ratios", 
      "mean FP-CIT caudate nucleus uptake", 
      "FP-CIT caudate nucleus uptake", 
      "caudate nucleus uptake", 
      "left caudate nucleus uptake", 
      "non-tremor control patients", 
      "ConclusionThe motor phenotype", 
      "caudate dopamine terminal loss", 
      "Parkinsonian dopaminergic degeneration", 
      "non-PD tremor", 
      "non-tremor Parkinson\u2019s disease"
    ], 
    "name": "Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson\u2019s disease", 
    "pagination": "1931-1937", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036293310"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-014-2796-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24867256"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-014-2796-5", 
      "https://app.dimensions.ai/details/publication/pub.1036293310"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_619.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-014-2796-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2796-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2796-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2796-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-014-2796-5'


 

This table displays all metadata directly associated to this object as RDF triples.

265 TRIPLES      22 PREDICATES      143 URIs      131 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-014-2796-5 schema:about N002cb0646e594e2796b40dd516ec8506
2 N10c83764db874f46bf6c7263706de0e9
3 N125f16e195fd4f60bebdaaacdac0225a
4 N32e634c673d0465d82764c7b93f13eeb
5 N40f8e01dcb49494b934a0986ac59992a
6 N5f4a7d46068a4e25a6deee13e55a577b
7 N6e6b3a900aa840de843909f9aca51fbe
8 N70c37b3a8cd9446398f0ace1ab05d4a9
9 N765b750c02bf404f8b56fa46adb35e5a
10 N8fdb7c848bf44b0790c4b84fb9d142bb
11 Na2fee818d7534f2c8d69db77de64308c
12 Nb42b665736c74f3e874329304340386a
13 Nc530e2493d464c77b4159db2f81d7562
14 Nce838d50805c41eebc05f2c5a27f1aeb
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author Nd58e8aac6403435485f55d85da57d813
18 schema:citation sg:pub.10.1007/s00259-012-2232-7
19 sg:pub.10.1007/s00259-012-2276-8
20 sg:pub.10.1007/s00702-006-0518-2
21 sg:pub.10.1038/nrneurol.2009.196
22 schema:datePublished 2014-05-28
23 schema:datePublishedReg 2014-05-28
24 schema:description PurposeParkinson’s disease (PD) can manifest with a tremor-dominant or a non-tremor (akinetic-rigid) phenotype. Although the tremor-dominant subtype may show a better prognosis, there is limited information on the phenotypic differences regarding the level of striatal dopamine transmission. The present study investigated striatal dopamine transporter (DAT) binding characteristics in a large sample of patients with and without tremor.Methods[123I]FP-CIT SPECT scans of 231 patients with a clinical diagnosis of PD and abnormal FP-CIT binding (157 with tremor, 74 without tremor) and 230 control patients with normal FP-CIT binding (148 with tremor, 82 without tremor) were analysed using an automated region-of-interest analysis of the scans (BRASS). Specific striatal binding ratios were compared between phenotypes and groups using age, sex, and symptom duration, predominant side of symptoms, dopaminergic medications and scanner as covariates.ResultsPatients with PD had 28.1 – 65.0 % lower binding in all striatal regions compared to controls (p < 0.001). The mean FP-CIT caudate nucleus uptake and the left caudate nucleus uptake were higher in PD patients with tremor than in PD patients without tremor (mean 9.0 % higher, left 10.5 % higher; p < 0.05), whereas there were no differences between tremor and non-tremor control patients. No significant effects of tremor on DAT binding were observed in the anterior or posterior putamen.ConclusionThe motor phenotype is associated with the extent of caudate dopamine terminal loss in PD, as dopamine function is relatively more preserved in tremor patients. Symptom type is related to caudate dopamine function only in association with Parkinsonian dopaminergic degeneration, not in intact dopamine systems in patients with non-PD tremor.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree false
28 schema:isPartOf N567bb30faaa74106a76630db5522bec8
29 Nd601d11bb4d54ea0a0d5e2086f7ab902
30 sg:journal.1297401
31 schema:keywords CIT SPECT scans
32 ConclusionThe motor phenotype
33 DAT binding
34 FP-CIT binding
35 FP-CIT caudate nucleus uptake
36 PD patients
37 Parkinson's disease
38 Parkinsonian dopaminergic degeneration
39 PurposeParkinson’s disease
40 ResultsPatients
41 SPECT scans
42 Specific striatal binding ratios
43 abnormal FP-CIT binding
44 age
45 analysis
46 anterior
47 association
48 better prognosis
49 binding
50 binding ratios
51 caudate dopamine terminal loss
52 caudate nucleus uptake
53 characteristics
54 clinical diagnosis
55 control
56 control patients
57 covariates
58 degeneration
59 density
60 diagnosis
61 differences
62 disease
63 dopamine function
64 dopamine system
65 dopamine terminal loss
66 dopamine transmission
67 dopamine transporter
68 dopamine transporter density
69 dopaminergic degeneration
70 dopaminergic medication
71 duration
72 effect
73 extent
74 function
75 group
76 information
77 intact dopamine system
78 interest analysis
79 large sample
80 left caudate nucleus uptake
81 levels
82 limited information
83 loss
84 low binding
85 mean FP-CIT caudate nucleus uptake
86 medications
87 motor phenotype
88 non-PD tremor
89 non-tremor (akinetic-rigid) phenotype
90 non-tremor Parkinson’s disease
91 non-tremor control patients
92 normal FP-CIT binding
93 nucleus uptake
94 patients
95 phenotype
96 phenotypic differences
97 posterior putamen
98 predominant side
99 present study
100 prognosis
101 putamen
102 ratio
103 region
104 samples
105 scanner
106 scans
107 sex
108 side
109 significant effect
110 striatal binding ratios
111 striatal dopamine transmission
112 striatal dopamine transporter
113 striatal dopamine transporter density
114 striatal regions
115 study
116 subtypes
117 symptom duration
118 symptom type
119 symptoms
120 system
121 terminal loss
122 transmission
123 transporter density
124 transporters
125 tremor
126 tremor patients
127 tremor-dominant subtype
128 types
129 uptake
130 schema:name Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease
131 schema:pagination 1931-1937
132 schema:productId N107078d1537b43168559c3f6e7601179
133 N8ea5d023d7654a7d885ea4950715acfb
134 N9453f693da804ec6b1abe2b59f872013
135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036293310
136 https://doi.org/10.1007/s00259-014-2796-5
137 schema:sdDatePublished 2021-11-01T18:20
138 schema:sdLicense https://scigraph.springernature.com/explorer/license/
139 schema:sdPublisher Ne2bf7f17b4444666aa6b3dfa8fad9e95
140 schema:url https://doi.org/10.1007/s00259-014-2796-5
141 sgo:license sg:explorer/license/
142 sgo:sdDataset articles
143 rdf:type schema:ScholarlyArticle
144 N002cb0646e594e2796b40dd516ec8506 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Parkinson Disease
146 rdf:type schema:DefinedTerm
147 N107078d1537b43168559c3f6e7601179 schema:name doi
148 schema:value 10.1007/s00259-014-2796-5
149 rdf:type schema:PropertyValue
150 N10c83764db874f46bf6c7263706de0e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Humans
152 rdf:type schema:DefinedTerm
153 N125f16e195fd4f60bebdaaacdac0225a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Radiopharmaceuticals
155 rdf:type schema:DefinedTerm
156 N32e634c673d0465d82764c7b93f13eeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Middle Aged
158 rdf:type schema:DefinedTerm
159 N40f8e01dcb49494b934a0986ac59992a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Tremor
161 rdf:type schema:DefinedTerm
162 N567bb30faaa74106a76630db5522bec8 schema:issueNumber 10
163 rdf:type schema:PublicationIssue
164 N5f4a7d46068a4e25a6deee13e55a577b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Aged
166 rdf:type schema:DefinedTerm
167 N6046a7b457cd4e58b7881385cf8c3159 rdf:first sg:person.015673636475.93
168 rdf:rest rdf:nil
169 N6e6b3a900aa840de843909f9aca51fbe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Female
171 rdf:type schema:DefinedTerm
172 N70c37b3a8cd9446398f0ace1ab05d4a9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Tomography, Emission-Computed, Single-Photon
174 rdf:type schema:DefinedTerm
175 N765b750c02bf404f8b56fa46adb35e5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Tropanes
177 rdf:type schema:DefinedTerm
178 N84cb5fe496e44253824286e69f4906b3 schema:affiliation grid-institutes:grid.470895.7
179 schema:familyName Kinos
180 schema:givenName Maija
181 rdf:type schema:Person
182 N8ea5d023d7654a7d885ea4950715acfb schema:name pubmed_id
183 schema:value 24867256
184 rdf:type schema:PropertyValue
185 N8f6a677eca3f4ad88655619ea6d2797f rdf:first sg:person.01231750412.31
186 rdf:rest N6046a7b457cd4e58b7881385cf8c3159
187 N8fdb7c848bf44b0790c4b84fb9d142bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Protein Binding
189 rdf:type schema:DefinedTerm
190 N9453f693da804ec6b1abe2b59f872013 schema:name dimensions_id
191 schema:value pub.1036293310
192 rdf:type schema:PropertyValue
193 Na2fee818d7534f2c8d69db77de64308c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
194 schema:name Neostriatum
195 rdf:type schema:DefinedTerm
196 Nb42b665736c74f3e874329304340386a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
197 schema:name Dopamine Plasma Membrane Transport Proteins
198 rdf:type schema:DefinedTerm
199 Nc530e2493d464c77b4159db2f81d7562 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Male
201 rdf:type schema:DefinedTerm
202 Nce838d50805c41eebc05f2c5a27f1aeb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Case-Control Studies
204 rdf:type schema:DefinedTerm
205 Nd58e8aac6403435485f55d85da57d813 rdf:first sg:person.0661656645.23
206 rdf:rest Nf528d4402979400f9dfc2857fa56f979
207 Nd601d11bb4d54ea0a0d5e2086f7ab902 schema:volumeNumber 41
208 rdf:type schema:PublicationVolume
209 Ne2bf7f17b4444666aa6b3dfa8fad9e95 schema:name Springer Nature - SN SciGraph project
210 rdf:type schema:Organization
211 Ne8068afff0b64e088e639c1483924984 rdf:first sg:person.0631212202.56
212 rdf:rest N8f6a677eca3f4ad88655619ea6d2797f
213 Nf528d4402979400f9dfc2857fa56f979 rdf:first N84cb5fe496e44253824286e69f4906b3
214 rdf:rest Ne8068afff0b64e088e639c1483924984
215 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
216 schema:name Medical and Health Sciences
217 rdf:type schema:DefinedTerm
218 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
219 schema:name Clinical Sciences
220 rdf:type schema:DefinedTerm
221 sg:journal.1297401 schema:issn 1619-7070
222 1619-7089
223 schema:name European Journal of Nuclear Medicine and Molecular Imaging
224 schema:publisher Springer Nature
225 rdf:type schema:Periodical
226 sg:person.01231750412.31 schema:affiliation grid-institutes:grid.410552.7
227 schema:familyName Seppänen
228 schema:givenName Marko
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231750412.31
230 rdf:type schema:Person
231 sg:person.015673636475.93 schema:affiliation grid-institutes:grid.410552.7
232 schema:familyName Noponen
233 schema:givenName Tommi
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015673636475.93
235 rdf:type schema:Person
236 sg:person.0631212202.56 schema:affiliation grid-institutes:grid.470895.7
237 schema:familyName Joutsa
238 schema:givenName Juho
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631212202.56
240 rdf:type schema:Person
241 sg:person.0661656645.23 schema:affiliation grid-institutes:grid.470895.7
242 schema:familyName Kaasinen
243 schema:givenName Valtteri
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661656645.23
245 rdf:type schema:Person
246 sg:pub.10.1007/s00259-012-2232-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004544665
247 https://doi.org/10.1007/s00259-012-2232-7
248 rdf:type schema:CreativeWork
249 sg:pub.10.1007/s00259-012-2276-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008102551
250 https://doi.org/10.1007/s00259-012-2276-8
251 rdf:type schema:CreativeWork
252 sg:pub.10.1007/s00702-006-0518-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051880746
253 https://doi.org/10.1007/s00702-006-0518-2
254 rdf:type schema:CreativeWork
255 sg:pub.10.1038/nrneurol.2009.196 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037082578
256 https://doi.org/10.1038/nrneurol.2009.196
257 rdf:type schema:CreativeWork
258 grid-institutes:grid.410552.7 schema:alternateName Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland
259 schema:name Department of Clinical Physiology and Nuclear Medicine, University of Turku and Turku University Hospital, Turku, Finland
260 Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland
261 rdf:type schema:Organization
262 grid-institutes:grid.470895.7 schema:alternateName Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland
263 schema:name Division of Clinical Neurosciences, University of Turku and Turku University Hospital, POB 52, 20521, Turku, Finland
264 Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland
265 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...